ArticleCureus2025
Myofibroblastoma of the Breast: A Case Report Highlighting the Importance of Accurate Diagnosis and Multidisciplinary Management.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Myofibroblastoma (MFB) of the breast is a rare benign mesenchymal tumor originating from mammary stromal cells, posing diagnostic challenges due to its diverse presentation. It typically affects older individuals, often postmenopausal women and men aged 40-87 years, presenting as a solitary, painless, well-defined, mobile mass that grows slowly. On mammography, MFB typically manifests as a well-circumscribed, non-calcified, round or oval mass, often of equal or high density, though margins can sometimes be obscured or indistinct, and rare coarse calcifications have been reported. Ultrasound findings are variable but often demonstrate a solid, irregular, non-circumscribed mass with varying posterior acoustic features and vascularity. Diagnosing MFB requires core needle biopsy and immunohistochemistry, as imaging findings are non-specific. However, MFB encompasses a broad morphologic spectrum beyond the classic spindle cell type and sometimes demonstrate mixed variants that can exhibit unusual or alarming features that make diagnosis challenging. A key feature is the presence of interspersed thick, hyalinized, and eosinophilic collagen bundles. Immunohistochemically, MFB characteristically shows strong positivity for CD34 and desmin. Treatment involves surgical excision, which is curative, and the prognosis is excellent with an extremely low risk of recurrence and no metastatic potential. Accurate differentiation from malignant mimics, particularly invasive lobular carcinoma and metaplastic carcinoma, is crucial. This case report describes a 41-year-old female who was found to have a suspicious right breast mass on a diagnostic ultrasound, later confirmed as MFB through pathology. Given the rarity of MFB, this case underscores the importance of accurate diagnosis and a multidisciplinary approach involving radiology, pathology, and surgery for appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.